NCT05678283View on ClinicalTrials.gov

A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 9, 2023

Primary Completion Date

April 29, 2024

Study Completion Date

April 29, 2024

Conditions
Advanced Solid Tumors
Interventions
DRUG

[14C]CC-90010

Specified dose on specified days

DRUG

CC-90010

Specified dose on specified days

Trial Locations (1)

28046

Local Institution - 0002, Madrid

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY